We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Pays $35M To Settle Elidel Marketing False Claims Lawsuit

Mealey's (October 11, 2016, 1:14 PM EDT) -- PHILADELPHIA — Novartis Pharmaceuticals Corp. will pay $35 million to resolve a whistle-blower’s claim that the drug maker marketed Elidel for use with children under 2 and as a first-line drug,...
To view the full article, register now.